SG11201608132UA - Controlled ovarian hyperstimulation with improved recombinant human follicle-stimulating hormone - Google Patents

Controlled ovarian hyperstimulation with improved recombinant human follicle-stimulating hormone

Info

Publication number
SG11201608132UA
SG11201608132UA SG11201608132UA SG11201608132UA SG11201608132UA SG 11201608132U A SG11201608132U A SG 11201608132UA SG 11201608132U A SG11201608132U A SG 11201608132UA SG 11201608132U A SG11201608132U A SG 11201608132UA SG 11201608132U A SG11201608132U A SG 11201608132UA
Authority
SG
Singapore
Prior art keywords
recombinant human
stimulating hormone
ovarian hyperstimulation
human follicle
controlled ovarian
Prior art date
Application number
SG11201608132UA
Inventor
Steffen Goletz
Lars Stöckl
Original Assignee
Glycotope Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glycotope Gmbh filed Critical Glycotope Gmbh
Publication of SG11201608132UA publication Critical patent/SG11201608132UA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/42—Gynaecological or obstetrical instruments or methods
    • A61B17/425—Gynaecological or obstetrical instruments or methods for reproduction or fertilisation
    • A61B17/43—Gynaecological or obstetrical instruments or methods for reproduction or fertilisation for artificial insemination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0608—Germ cells
    • C12N5/0609—Oocytes, oogonia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Surgery (AREA)
  • Pregnancy & Childbirth (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SG11201608132UA 2014-04-18 2015-04-17 Controlled ovarian hyperstimulation with improved recombinant human follicle-stimulating hormone SG11201608132UA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461981621P 2014-04-18 2014-04-18
PCT/EP2015/058352 WO2015158875A1 (en) 2014-04-18 2015-04-17 Controlled ovarian hyperstimulation with improved recombinant human follicle-stimulating hormone

Publications (1)

Publication Number Publication Date
SG11201608132UA true SG11201608132UA (en) 2016-11-29

Family

ID=53015773

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201608132UA SG11201608132UA (en) 2014-04-18 2015-04-17 Controlled ovarian hyperstimulation with improved recombinant human follicle-stimulating hormone

Country Status (13)

Country Link
US (1) US20170035854A1 (en)
EP (1) EP3131571A1 (en)
JP (1) JP2017513853A (en)
KR (1) KR20160144480A (en)
CN (1) CN106413735A (en)
AR (1) AR100132A1 (en)
AU (1) AU2015248793A1 (en)
BR (1) BR112016023668A2 (en)
CA (1) CA2945883A1 (en)
IL (1) IL248362A0 (en)
MX (1) MX2016013449A (en)
SG (1) SG11201608132UA (en)
WO (1) WO2015158875A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI488640B (en) 2008-04-16 2015-06-21 Ferring Int Ct Sa Pharmaceutical preparation
WO2018080120A1 (en) * 2016-10-28 2018-05-03 Samsung Electronics Co., Ltd. Method and apparatus for follicular quantification in 3d ultrasound images
CA3073624A1 (en) * 2017-09-01 2019-03-07 Ferring B.V. Composition for controlled ovarian stimulation
CN110570952B (en) * 2018-06-05 2022-04-12 北京大学第三医院 System for predicting the probability of hyporesponsiveness of a subject's ovary under an antagonist regimen and system for guiding the selection of initial dosage of gonadotropins
CN112603990B (en) * 2020-12-17 2022-03-08 广州医药研究总院有限公司 Kit for increasing number of canine ovarian cumulus-oocyte complexes and application thereof
CN116798634B (en) * 2023-08-25 2023-11-21 北京大学深圳医院 FSH start dose prediction system, electronic equipment and storage medium

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002340562B2 (en) 2001-10-22 2008-10-23 Merck Serono Sa Compositions of FSH with high sialylation degree and their use for the preparation of medicaments
CA2773240C (en) * 2009-09-22 2015-11-10 Volker Sandig Process for producing molecules containing specialized glycan structures
EP2325194A1 (en) 2009-11-24 2011-05-25 Glycotope GmbH Process for the purification of glycoproteins
WO2012016576A1 (en) 2010-08-04 2012-02-09 Glycotope Gmbh Improved recombinant human follicle-stimulating hormone

Also Published As

Publication number Publication date
AU2015248793A1 (en) 2016-11-03
BR112016023668A2 (en) 2017-10-17
AR100132A1 (en) 2016-09-14
KR20160144480A (en) 2016-12-16
MX2016013449A (en) 2017-05-04
CA2945883A1 (en) 2015-10-22
EP3131571A1 (en) 2017-02-22
CN106413735A (en) 2017-02-15
WO2015158875A1 (en) 2015-10-22
US20170035854A1 (en) 2017-02-09
IL248362A0 (en) 2016-11-30
JP2017513853A (en) 2017-06-01

Similar Documents

Publication Publication Date Title
IL281273A (en) Modified fgf-21 polypeptides and uses thereof
IL275307B (en) Syntac polypeptides and uses thereof
HK1252893A1 (en) Stabilized anti-microbial peptides
IL248362A0 (en) Controlled ovarian hyperstimulation with improved recombinant human follicle-stimulating hormone
GB201411062D0 (en) Improvements in movement control devices
ZA201802017B (en) Novel insulin analogs and use thereof
LT3297653T (en) Treatment of post-bariatric hypoglycemia with glp-1 antagonists
GB201513483D0 (en) Load control apparatus
IL247551B (en) Dry-powder peptide medicament
IL266090A (en) Recombinant bagworm silk
IL257815A (en) Mammalian follicle-stimulating hormone composition with increased stability
GB201412268D0 (en) Gesture control
GB201410031D0 (en) Polypeptides and uses thereof
GB201516978D0 (en) Device control
HK1204432A2 (en) Lighting control device with multiple switch
IL265258A (en) Use of recombinant lymphocyte activation gene-3
PT3250234T (en) Recombinant mdv1 and the uses thereof
SG11201702779PA (en) Microneedle device containing recombinant follicle stimulating hormone
GB2539040B (en) Issue policy control
RS62066B1 (en) Modified fgf-21 polypeptides and uses thereof
GB201300529D0 (en) Recombinant polypeptide